Exact Mass: 665.3238

2alpha,7beta,13alpha-triacetoxy-5alpha-(3-dimethylamino-3-phenyl)propionyloxy-2(3->20)-abeo-taxa-9,10-dione

C37H47NO10 (665.32)

Phe Lys Trp Trp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

Phe Trp Lys Trp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]-3-(1H-indol-3-yl)propanoic acid

Phe Trp Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

Lys Phe Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

Lys Trp Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

Lys Trp Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

Trp Phe Lys Trp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]hexanamido]-3-(1H-indol-3-yl)propanoic acid

Trp Phe Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

Trp Lys Phe Trp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]hexanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

Trp Lys Trp Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

Trp Trp Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]hexanoic acid

Trp Trp Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]-3-phenylpropanoic acid

HAYYL

His Ala Tyr Tyr Leu

PKODiA-PS

1-hexadecanoyl-2-(5-oxo-7-carboxy-6E-heptenoyl)-sn-glycero-3-phosphoserine

C30H52NO13P (665.3176)

Boc-Phe-Ser-Arg-AMC

Rilzabrutinib

C36H40FN9O3 (665.3238)

C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent

(2S)-2-amino-3-[[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

phosphatidylinositol 22:2(1-)

C31H54O13P (665.3302)

A 1-phosphatidyl-1D-myo-inositol(1-) in which the two acyl groups contain a total of 22 carbons and 2 double bonds.

PE 20:4/9:4;O2

PE 22:5/7:3;O2

PE 22:6/7:2;O2

PE 29:8;O2

LNAPS 28:7

PS 16:0/8:3;O3

C30H52NO13P (665.3176)

PS 16:1/8:2;O3

C30H52NO13P (665.3176)

2-[(2s,5s,11r,14s,17r)-5-benzyl-11-[(2r)-butan-2-yl]-3,6,9,12,15,18-hexahydroxy-17-[(4-hydroxyphenyl)methyl]-14-methyl-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]ethanimidic acid

2-[(2s,5s,11r,14s,17r)-5-benzyl-11-[(2r)-butan-2-yl]-3,6,9,12,15,18-hexahydroxy-17-[(4-hydroxyphenyl)methyl]-14-methyl-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]ethanimidic acid

(3z)-2,7,13-tris(acetyloxy)-8,12,15,15-tetramethyl-9,10-dioxotricyclo[9.3.1.1⁴,⁸]hexadeca-3,11-dien-5-yl 3-(dimethylamino)-3-phenylpropanoate

C37H47NO10 (665.32)

2-[(2s,5s,11s,14s,17s)-5-benzyl-3,6,9,12,15,18-hexahydroxy-17-[(4-hydroxyphenyl)methyl]-14-methyl-11-(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]ethanimidic acid

2-[(2s,5s,11s,14s,17s)-5-benzyl-3,6,9,12,15,18-hexahydroxy-17-[(4-hydroxyphenyl)methyl]-14-methyl-11-(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]ethanimidic acid